 |
市場調査レポート
商品コード
1458063
バイオ分析試験サービスの世界市場規模、シェア、成長分析：ワークフロー別、試験別 - 産業予測（2024年～2031年）Global Bioanalytical Testing Services Market Size, Share, Growth Analysis, By Workflow(Sample Preparation, and Sample Analysis), By Test(ADME, PK) - Industry Forecast 2024-2031 |
||||||
| バイオ分析試験サービスの世界市場規模、シェア、成長分析：ワークフロー別、試験別 - 産業予測（2024年～2031年） |
|
出版日: 2024年03月28日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
バイオ分析試験サービスの世界市場規模は、2022年に24億2,000万米ドルと評価され、予測期間中（2024年～2031年）のCAGRは15%で、2023年の27億8,000万米ドルから2031年には85億1,000万米ドルに成長する見通しです。
バイオ分析試験サービス市場は、製薬企業やバイオテクノロジー企業に信頼できる精密な試験ソリューションを提供し、安全で効能の高い医薬品の開発を支援することを目的としています。世界のバイオ分析試験サービス市場の主な促進要因は、医薬品開発と薬事承認サービスに対する需要の高まりです。製薬・バイオテクノロジー分野の急速な拡大に伴い、信頼性が高く正確な試験サービスへの要求が高まっています。しかし、世界のバイオ分析試験サービス市場の主な課題は、これらのサービスに関連する高コストです。世界のバイオ分析試験サービス市場における重要なハードルは、分析方法と手順が標準化されていないことに関係しています。さまざまなサービスプロバイダーが採用する手法や手順がばらつくと、結果に一貫性がなくなり、生成されるデータの信頼性が損なわれる可能性があります。このような課題にもかかわらず、世界のバイオ分析試験サービス市場は、サービスプロバイダーにいくつかの機会を提供しています。個別化医療と標的治療に対する需要が急増しているため、より専門化されたテーラーメイドの試験サービスの必要性が高まっています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
バイオ分析試験サービスの世界市場：ワークフロー別
- 市場概要
- サンプル調製
- サンプル分析
バイオ分析試験サービスの世界市場：試験別
- 市場概要
- ADME
- PK
- PD
- 生物学的利用能
- 生物学的同等性
- その他
バイオ分析試験サービスの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Eurofins Scientific SE（Luxembourg）
- Charles River Laboratories International, Inc.（USA）
- Laboratory Corporation of America Holdings（USA）
- WuXi AppTec（China）
- PPD, Inc.（USA）
- Frontage Laboratories, Inc.（USA）
- SGS SA（Switzerland）
- ICON plc（Ireland）
- Intertek Group plc（UK）
- Bioanalytical Systems, Inc.（USA）
- Almac Group（UK）
- Anapharm（Canada）
- Pharmaron Beijing Co., Ltd.（China）
- Syneos Health（USA）
- Celerion（USA）
- BioAgilytix Labs（USA）
- Medpace Holdings, Inc.（USA）
- LGC Limited（UK）
- PSI CRO AG（Switzerland）
- Bioclinica（USA）
Global bioanalytical testing services market size was valued at USD 2.42 billion in 2022 and is poised to grow from USD 2.78 billion in 2023 to USD 8.51 billion by 2031, at a CAGR of 15 % during the forecast period (2024-2031).
The bioanalytical testing services market aims to deliver dependable and precise testing solutions to pharmaceutical and biotech firms, aiding them in the development of safe and efficacious drugs. The principal driver behind the global bioanalytical testing services market is the escalating demand for drug development and regulatory approval services. As the pharmaceutical and biotech sectors undergo rapid expansion, there is a growing requirement for trustworthy and accurate testing services. However, the primary challenge for the global bioanalytical testing services market is the high cost associated with these services. A significant hurdle in the global bioanalytical testing services market pertains to the lack of standardization in analytical methods and procedures. Divergence in the methodologies and procedures employed by various service providers may result in inconsistent outcomes, thereby jeopardizing the reliability of the generated data. Despite these challenges, the global bioanalytical testing services market presents several opportunities for service providers. The burgeoning demand for personalized medicine and targeted therapies is propelling the necessity for more specialized and tailored testing services.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bioanalytical Testing Services Market Segmental Analysis
The global bioanalytical testing services market is segmented based on workflow, test, and region. By workflow, the market is segmented into sample preparation, and sample analysis. By test, the market is segmented into ADME, PK, PD, bioavailability, bioequivalence, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Bioanalytical Testing Services Market
There is a rising demand for personalized medicine, and bioanalytical testing services are pivotal in the development and evaluation of personalized drugs. These tests are instrumental in assessing the efficacy of drugs on individual patients and assist in determining the most suitable treatment regimen for patients. For example, in 2021, Q^2 Solutions, a leading provider of clinical trials laboratory services globally, broadened its biomarker capabilities to bolster the clinical advancement of personalized medicine. This expansion encompassed the establishment of a cutting-edge flow cytometry laboratory in Scotland, UK.
Restraints in the Global Bioanalytical Testing Services Market
An important factor expected to hinder the growth of the bioanalytical testing services market is the scarcity of qualified individuals proficient in operating the sophisticated equipment essential for conducting bioanalytical tests. According to the US Bureau of Labor Statistics, by 2020, there are projected to be 18,580 vacancies in clinical laboratory science (CLS) programs across the nation. However, only approximately 5,000 students complete accredited CLS programs each year. This indicates that educational programs are producing less than one-third of the necessary trained professionals. Consequently, the adoption of new technologies and methodologies may encounter challenges, potentially constraining the market's future growth.
Market Trends of the Global Bioanalytical Testing Services Market
Pharmaceutical companies are progressively turning to third-party service providers to outsource bioanalytical testing services, aiming to cut costs, enhance efficiency, and concentrate on their core strengths. This outsourcing trend is anticipated to persist in the foreseeable future.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Bioanalytical Testing Services Market by Workflow
- Market Overview
- Sample Preparation
- and Sample Analysis
Global Bioanalytical Testing Services Market by Test
- Market Overview
- ADME
- PK
- PD
- Bioavailability
- Bioequivalence
- and Others
Global Bioanalytical Testing Services Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PPD, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioanalytical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Anapharm (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pharmaron Beijing Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Syneos Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Celerion (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioAgilytix Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LGC Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PSI CRO AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioclinica (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
